Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Límite
Tipo del documento
Revista
País de afiliación
Intervalo de año de publicación
1.
Gut ; 66(2): 342-351, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-26669617

RESUMEN

OBJECTIVE: The nature of the tumour-infiltrating leucocytes (TILs) is known to impact clinical outcome in carcinomas, including hepatocellular carcinoma (HCC). However, the role of tumour-infiltrating B cells (TIBs) remains controversial. Here, we investigate the impact of TIBs and their interaction with T cells on HCC patient prognosis. DESIGN: Tissue samples were obtained from 112 patients with HCC from Singapore, Hong Kong and Zurich and analysed using immunohistochemistry and immunofluorescence. RNA expression of CD19, CD8A, IFNG was analysed using quantitative PCR. The phenotype of freshly isolated TILs was analysed using flow cytometry. A mouse model depleted of mature B cells was used for functional study. RESULTS: Tumour-infiltrating T cells and B cells were observed in close contact with each other and their densities are correlated with superior survival in patients with HCC. Furthermore, the density of TIBs was correlated with an enhanced expression of granzyme B and IFN-γ, as well as with reduced tumour viability defined by low expression of Ki-67, and an enhanced expression of activated caspase-3 on tumour cells. CD27 and CD40 costimulatory molecules and TILs expressing activation marker CD38 in the tumour were also correlated with patient survival. Mice depleted of mature B cells and transplanted with murine hepatoma cells showed reduced tumour control and decreased local T cell activation, further indicating the important role of B cells. CONCLUSIONS: The close proximity of tumour-infiltrating T cells and B cells indicates a functional interaction between them that is linked to an enhanced local immune activation and contributes to better prognosis for patients with HCC.


Asunto(s)
Antígenos CD/análisis , Linfocitos B/inmunología , Carcinoma Hepatocelular/inmunología , Neoplasias Hepáticas/inmunología , Linfocitos Infiltrantes de Tumor , Linfocitos T/inmunología , ADP-Ribosil Ciclasa 1/análisis , Adulto , Anciano , Anciano de 80 o más Años , Animales , Antígenos CD19/genética , Antígenos CD20/análisis , Linfocitos B/química , Linfocitos B/patología , Complejo CD3/análisis , Antígenos CD40/análisis , Antígenos CD8/análisis , Antígenos CD8/genética , Carcinoma Hepatocelular/química , Carcinoma Hepatocelular/patología , Caspasa 3/análisis , Progresión de la Enfermedad , Femenino , Expresión Génica , Granzimas/análisis , Humanos , Interferón gamma/genética , Antígeno Ki-67/análisis , Neoplasias Hepáticas/química , Neoplasias Hepáticas/patología , Depleción Linfocítica , Masculino , Ratones , Ratones Endogámicos C57BL , Persona de Mediana Edad , Fenotipo , Estudios Retrospectivos , Tasa de Supervivencia , Linfocitos T/química , Linfocitos T/patología , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/análisis , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA